Persons with CKD have significantly higher rates of morbidity, mortality, hospitalizations, and healthcare utilization. Chronic kidney disease may be caused due to comorbid conditions such as high blood pressure, etc. This can lead to buildup of metabolic wastes in patient’s blood and make them feel sick. Chronic kidney disease complications include high blood pressure, anemia (low blood count), weak bones, poor nutritional health, and nerve damage. Chronic kidney disease also increases the risk of developing heart and blood vessel diseases such as heart attack, stroke, etc. These problems may happen slowly over a long period of time.
Market Dynamics
Key players are involved in announcing their results for the clinical trials conducted for the antihypertensive drugs, in order to find the treatment for hypertension in patients suffering from chronic kidney disease. For instance, in 2018, Novartis International AG announced positive results for Entresto (sacubitril/valsartan). According to the clinical trials conducted by the company, it was found that Entresto (sacubitril/valsartan) helped to preserve kidney function in patients suffering from cardiovascular diseases. Moreover, Entresto (sacubitril/valsartan) belongs to angiotensin receptor blockers (ARBs) drug class.
The increasing number of patients undergoing dialysis treatment is expected to drive growth of the global hypertension in CKD market. For instance, according to the data published in the Indian Journal of Public Health (IJPH), in 2018, around 130,000 patients received dialysis treatment in India and the number increased by around 232 patients per million population in India as compared to 2017.
Key features of the study:
- This report provides an in-depth analysis of global hypertension in CKD market , provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global hypertension in CKD market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
- Key companies covered as a part of this study include Sanofi S.A, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, AstraZeneca Plc, Novartis International AG, C.H. Boehringer Sohn AG & Ko. KG, Kissei Pharmaceutical Co., Ltd., Reata Pharmaceuticals, Inc., Ardelyx, and KBP Biosciences Holdings Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global hypertension in CKD market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the hypertension in CKD market
- Global Hypertension in CKD Market, By Drug Class:
- Diuretics
- RAS Blockade
- β - Blockers
- Calcium Channel Blockers
- Others
- Global Hypertension in CKD Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Hypertension in CKD Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Sanofi S.A
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- AstraZeneca Plc
- Novartis International AG
- C.H. Boehringer Sohn AG & Ko. KG
- Kissei Pharmaceutical Co., Ltd.
- Reata Pharmaceuticals, Inc.
- Ardelyx,
- KBP Biosciences Holdings Limited
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Key Developments
- Pipeline analysis
- Regulatory Scenario
- Key Developments
- Treatment Approaches
- PEST Analysis
- 4. Global Hypertension in CKD Market – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Hypertension in CKD Market, By Drug Class, 2020 - 030, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Diuretics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Segment Trends
- RAS Blockade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Segment Trends
- β-Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Segment Trends
- Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Segment Trends
- Others (α-Blockers, Vasodilators, Proteinuria, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Segment Trends
- 6. Global Hypertension in CKD Market, By Distribution Channel, 2020 – 2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- 7. Global Hypertension in CKD Market, By Region, 2020 – 2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2020 –2032, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2020–2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 –2032, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2020 –2032, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2020–2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 –2032, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2020 –2032, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2020–2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 –2032, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2020 –2032, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2020–2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 –2032, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2020 –2032, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2020–2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 –2032, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2020 –2032, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2020–2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2020 –2032, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- 8. Competitive Landscape
- Company Profiles
- Sanofi S.A
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- AstraZeneca Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- C.H. Boehringer Sohn AG & Ko. KG Kissei Pharmaceutical Co., Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- KBP Biosciences Holdings Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Ardelyx
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Reata Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Kissei Pharmaceutical Co., Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bayer Pharmaceuticals, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- GSK plc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- 9. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 20 market data tables and 28 figures on “Global Hypertension in CKD Market” – Global forecast to 2032
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook